Pistachio Intake and Nutrition-Related Outcomes in Individuals on GLP-1 Therapy
Recruiting · NCT07244445 · Interventional (participants receive a specific treatment) · Lead sponsor: Ian J. Neeland, MD
View the official record on ClinicalTrials.gov →Interventions studied
Dual-energy X-ray absorptiometry (DEXA) scansPistachios
What this trial is about
In this study will look at how eating pistachios every day might affect participants weight, how healthy their diet is, and how they feel when eating. Investigators want to see if adding pistachios to meals for 12 weeks helps participants feel fuller, have more energy, and improve body composition. The study will include adults who have been taking GLP-1 medicines like semaglutide or tirzepatide for at least three months. Investigators also want to see if eating pistachios improves overall diet quality and health markers like tiredness and certain levels in blood.
Who can take part
Age range
18 Years to 80 Years
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Individuals with a BMI ≥30 kg/m2 or with a BMI ≥27 kg/m2 with at least one weight-related comorbidity who have been continuously using semaglutide or tirzepatide for three months for a clinical indication and remain on the therapy at the time of enrollment
Exclusion criteria
- No use or contraindication to use of a GLP-1 RA
- Known allergy to nuts
- Pregnant or breastfeeding
- Incarcerated
Where it is running
1 location listed across 1 US state.
- University Hospitals Cleveland Medical Center - Clevland, Ohio, United States